| Title |
Author |
Type |
Date |
Words |
| Regeneron announces initial data from Phase 1/2 trial of REGN5678 with Libtayo. |
|
|
Aug 3, 2022 |
613 |
| HCW Biologics announces US issued patent for platform technology. |
|
|
Aug 3, 2022 |
204 |
| LATEST COMPANY NEWS. |
|
|
Aug 3, 2022 |
16743 |
| Update on the Classification of and Diagnostic Approaches to Mature T-Cell Lymphomas. |
Zhang, Xiaohui; Zhou, Jiehao; Han, Xin; Wang, Endi; Zhang, Linsheng |
|
Aug 1, 2022 |
5518 |
| TEVOGEN BIO ESTABLISHES PHILADELPHIA R&D CENTER. |
|
|
Jul 30, 2022 |
506 |
| Effect of Intervention of Probiotics in Advance on Treg/Th17 in Premature Mice. |
Liu, Mengmeng; Mao, Juanjuan; Zhang, Shifa |
|
Jul 30, 2022 |
4699 |
| SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia. |
Ngalamika, Owen; Mukasine, Marie Claire; Kamanzi, Patrick; Kawimbe, Musonda; Mujajati, Aaron; Tso, F |
|
Jul 28, 2022 |
5804 |
| Intratumoral IL-28B Gene Delivery Elicits Antitumor Effects by Remodeling of the Tumor Microenvironment in H22-Bearing Mice. |
Li, Zhi; Wang, Jianghua; Chen, Chong; He, Qi; Xu, Xiaoying; Da, Zejiao; Wang, Bo |
|
Jul 28, 2022 |
7382 |
| Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases. |
Shandil, Radha Krishan; Dhup, Saumya; Narayanan, Shridhar |
|
Jul 28, 2022 |
7604 |
| In8bio provides clinical update from ongoing Phase 1 trial of INB-100. |
|
|
Jul 27, 2022 |
224 |
| Kite's CAR T-cell Therapy Tecartus Receives Positive CHMP Opinion in Relapsed or Refractory Acute Lymphoblastic Leukemia. |
|
|
Jul 26, 2022 |
527 |
| MRGBP: A New Factor for Diagnosis and Prediction of Head and Neck Squamous Cell Carcinoma. |
Zhao, Cheng; Wei, Chuang; Chen, Xiatian; Li, Peifeng |
|
Jul 25, 2022 |
4252 |
| Upregulated Expression of IL2RB Causes Disorder of Immune Microenvironment in Patients with Kawasaki Disease. |
Liao, Yunfei; Ke, Ben; Long, Xiaoyan; Xu, Jianjun; Wu, Yongbing |
|
Jul 25, 2022 |
7859 |
| mTOR Modulates the Endoplasmic Reticulum Stress-Induced CD4[sup.+] T Cell Apoptosis Mediated by ROS in Septic Immunosuppression. |
Wang, Hao; Chen, Jianwei; Bai, Guangxu; Han, Wen; Guo, Ran; Cui, Na |
|
Jul 23, 2022 |
6502 |
| Cognition/Psychological Burden and Resilience in Cutaneous T-Cell Lymphoma and Psoriasis Patients: Real-Life Data and Implications for the Treatment. |
Damiani, Giovanni; Tacastacas, Joselin D.; Wuerz, Timothy; Miller, Lindsay; Fastenau, Philip; Bailey |
|
Jul 21, 2022 |
6298 |
| Covaxin booster dose dramatically increases neutralizing antibody responses: Study. |
|
|
Jul 21, 2022 |
386 |
| In8bio announces issuance of European patent covering matter for DRI platform. |
|
|
Jul 21, 2022 |
282 |
| Sangamo gets EC OMPD to CAR-Treg cell therapy TX200 for organ transplantation. |
|
|
Jul 21, 2022 |
238 |
| European Orphan Medicinal Product Designation Granted to Sangamo Therapeutics Investigational CAR-Treg Cell Therapy TX200 for Solid Organ Transplantation. |
|
|
Jul 21, 2022 |
434 |
| BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity. |
Liu, Junxiu; Tian, Tian; Liu, Xiangyu; Cui, Zhumei |
|
Jul 21, 2022 |
7917 |
| Wugen Receives US FDA Fast Track and Rare Pediatric Disease Designations for WU-CART-007 for the Treatment of R/R T-ALL/LBL. |
|
|
Jul 19, 2022 |
383 |
| Bioinformatics Analysis Reveals an Association between Autophagy, Prognosis, Tumor Microenvironment, and Immunotherapy in Osteosarcoma. |
Ma, Yibo; Tong, Changgui; Xu, Mingjun; He, Hongtao; Chen, Changjian |
|
Jul 14, 2022 |
5561 |
| NeoImmuneTech's NT-I7 receives US FDA Orphan Drug Designation. |
|
|
Jul 14, 2022 |
316 |
| NeoImmuneTech's NT-I7 receives US FDA Orphan Drug Designation. |
|
|
Jul 14, 2022 |
315 |
| Top doctor explains why everyone must get a booster jab. |
|
|
Jul 14, 2022 |
263 |
| Atara Biotherapeutics Completes the ATA188 Phase 2 EMBOLD Study Interim Analysis in Patients with Progressive MS. |
|
Clinical report |
Jul 13, 2022 |
607 |
| SQZ Biotechnologies and Collaborators Publish Technology Review on SQZ APCs and Effective CD8 T Cell Activation. |
|
|
Jul 13, 2022 |
637 |
| Identification of APC Mutation as a Potential Predictor for Immunotherapy in Colorectal Cancer. |
Feng, Fen; Sun, Huake; Zhao, Zhikun; Sun, Chao; Zhao, Yongtian; Lin, Hanqing; Yang, Jie |
|
Jul 13, 2022 |
4484 |
| Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer. |
Liu, Guiyuan; Chen, Dehu; Zhao, Xiaojun; You, Xiaolan; Huang, Chuanjiang; Cheng, Zhiyi; Mao, Xunan |
|
Jul 12, 2022 |
4095 |
| SQZ Biotechnologies announces publication of review on APCs. |
|
|
Jul 12, 2022 |
166 |
| TScan Therapeutics announces publication highlighting tumor antigens, TCRs. |
|
|
Jul 11, 2022 |
304 |
| Immunocore announces dosing of first patient with ImmTAV bispecific for HIV. |
|
|
Jul 11, 2022 |
212 |
| Electroacupuncture at Zusanli (ST36), Guanyuan (CV4), and Qihai (CV6) Acupoints Regulates Immune Function in Patients with Sepsis via the PD-1 Pathway. |
Yang, Guang; Zheng, BoJun; Yu, Yi; Huang, Jing; Zhu, HongFa; Deng, DingWei; Li, Jian |
Report |
Jul 11, 2022 |
6367 |
| Study on the Prognostic Values of TTC36 Correlated with Immune Infiltrates and Its Methylation in Hepatocellular Carcinoma. |
Jing, Wei; Peng, Ruoyu; Li, Xiaogai; Lv, Shaogang; Duan, Yu; Jiang, Shitao |
Report |
Jul 8, 2022 |
4738 |
| FDA Grants Priority Review to Genentech's Mosunetuzumab for People with Relapsed or Refractory Follicular Lymphoma. |
|
|
Jul 7, 2022 |
824 |
| CD226 Deficiency Alleviates Murine Allergic Rhinitis by Suppressing Group 2 Innate Lymphoid Cell Responses. |
Xie, Yang; Zhang, Yuan; Zhu, Tianxiao; Ma, Jingchang; Duan, Chujun; Yang, Lu; Wang, Tingting |
|
Jul 7, 2022 |
6373 |
| Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer. |
Li, Wei; Lu, Zhe; Pan, Dongqing; Zhang, Zejian; He, Hua; Wu, Jiacheng; Peng, Naixiong |
|
Jul 6, 2022 |
6316 |
| SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer. |
Yu, Pengcheng; He, Weiyang; Zhang, Yanqiang; Hu, Can; Wu, Yue; Wang, Yi; Bao, Zhehan |
|
Jul 5, 2022 |
6799 |
| Immunomodulatory Effects of Lepidium meyenii Walp. Polysaccharides on an Immunosuppression Model Induced by Cyclophosphamide. |
Fei, Wen-ting; Yue, Na; Li, Ai-min; Yu, Shu-hui; Zhao, Dan-ping; Zhu, Ying-li; Wang, Chun |
|
Jul 4, 2022 |
7202 |
| EDUCATION CITY STUDENTS HONE SKILLS IN FUTURE LEARNING ACADEMY HOSTED BY QF PARTNER TEXAS A&M AT QATAR. |
|
|
Jul 3, 2022 |
626 |
| Education City students hone skills in Future Learning Academy hosted by Tamuq. |
|
|
Jul 2, 2022 |
620 |
| Immune Targeted Therapies for COVID-19 Infection: A Narrative Review. |
Forouzani-Haghighi, Bahareh; Rezvani, Alireza; Vazin, Afsaneh |
|
Jul 1, 2022 |
5466 |
| SQZ DEBUTS INTEGRATED POC CELL THERAPY SYSTEM. |
|
Clinical report |
Jul 1, 2022 |
940 |
| Cyclacel Pharmaceuticals achieves key business objectives in 1H22. |
|
|
Jun 30, 2022 |
350 |
| Effect of Montelukast sodium combined with Budesonide aerosol on airway function and T lymphocytes in asthmatic children. |
Wei Jin, Zichong Zhao and Dongping Zhou |
|
Jun 30, 2022 |
2741 |
| Gingiva-Derived Mesenchymal Stem Cells Attenuate Imiquimod- (IMQ-) Induced Murine Psoriasis-Like Skin Inflammation. |
Ye, Ziyu; Liang, Yanfang; Lin, Bihua; Li, Yanyun; Chai, Xingxing; Lian, Jiachun; Zhang, Xueying |
|
Jun 30, 2022 |
6234 |
| A Risk Model Based on Sorafenib-Response Target Genes Predicts the Prognosis of Patients with HCC. |
Liu, Xiang; Zeng, Jian; Li, Huanyu; Li, Feng; Jiang, Bin; Zhao, Ming; Liu, Zhuo |
|
Jun 28, 2022 |
7260 |
| A Novel Angiogenesis-Related Gene Signature to Predict Biochemical Recurrence of Patients with Prostate Cancer following Radical Therapy. |
Fan, Bohan; Wang, Yicun; Zheng, Xin; Zhang, Xin; Zhang, Zijian; Hu, Xiaopeng |
|
Jun 28, 2022 |
6696 |
| Integrated Single-Cell RNA-Sequencing Analysis of Gastric Cancer Identifies FABP1 as a Novel Prognostic Biomarker. |
Yang, Fan; Gan, Lianfang; Pan, Junhua; Chen, Yaying; Zhang, Hong; Huang, Ling |
|
Jun 28, 2022 |
5955 |
| Fate Therapeutics announces expansion of collaboration with ONO Pharmaceutical. |
|
|
Jun 28, 2022 |
252 |
| Effects of tumor derived exosomes on T cells markers expression/Efeitos de exossomos derivados de tumor na expressao de marcadores de celulas T. |
Hussain, S.; Malik, S.I. |
|
Jun 28, 2022 |
5000 |
| Alaunos Therapeutics, NCI expand CRADA to 2025. |
|
|
Jun 27, 2022 |
158 |
| Immunocore announces initial data from Phase 1 ImmTAV trial. |
|
|
Jun 26, 2022 |
340 |
| An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer. |
Huang, Changchang; Cui, Hongyin; Lang, Xiaolin; Zhao, Fen |
|
Jun 26, 2022 |
3892 |
| gp96 Expression in Gliomas and Its Association with Tumor Malignancy and T Cell Infiltrating Level. |
Li, Chunzhao; Wang, Yi; Long, Lang; Zhang, Peng; Zhang, Yang; Ji, Nan |
|
Jun 26, 2022 |
7094 |
| Construction of Metabolic Molecular Classification and Immune Characteristics for the Prognosis Prediction of Ovarian Cancer. |
Wang, Kexin; He, Hui; Feng, Xue |
|
Jun 25, 2022 |
8514 |
| Analysis on the Efficacy of Bronchial Artery Chemoembolization Combined with 125I Seed Implantation in the Therapy of Advanced Non-Small-Cell Lung Cancer Based on the Medical Database. |
Xie, Peng; He, Lidong; Zhang, Yan |
Report |
Jun 24, 2022 |
4388 |
| US FDA Approves Bristol Myers Squibb's CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy. |
|
|
Jun 24, 2022 |
520 |
| A breakthrough in Hemo-Oncology. |
|
|
Jun 24, 2022 |
584 |
| BioNTech receives PRIME designation for BNT211 in testicular cancer. |
|
|
Jun 23, 2022 |
222 |
| Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis. |
Huang, Zhehao; Wang, Hailiang; Sun, Dongjie; Liu, Jun |
Report |
Jun 23, 2022 |
5805 |
| SNHG5/miR-299-5p/ATF2 Axis as a Biomarker in Immune Microenvironment of Intervertebral Disc Degeneration. |
Shi, Yu; Guo, Rong; Zeng, Yanyan; Fang, Qian; Wang, Xianglong; Liu, Wei; Huang, Guozhi |
|
Jun 23, 2022 |
6177 |
| Osimertinib Improves the Immune Microenvironment of Lung Cancer by Downregulating PD-L1 Expression of Vascular Endothelial Cells and Enhances the Antitumor Effect of Bevacizumab. |
Xiao, Xuejun; Wu, Yang; Shen, Fang; MuLaTiAize, Yusufu; Xinhua, Nabi |
|
Jun 23, 2022 |
4944 |
| Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD[sub.3]+CD[sub.56]+ NKT-Like Cells. |
Zhu, Siyu; Zhang, Chen; Sun, Qian; Wang, Yang; Yu, Wenwen; Wei, Feng; Ren, Xiubao |
|
Jun 23, 2022 |
5590 |
| Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors. |
Zhang, Mengqi; Wang, Lulu; Liu, Wan; Wang, Tian; De Sanctis, Francesco; Zhu, Lifang; Zhang, Guizhong |
|
Jun 22, 2022 |
10540 |
| Mustang Bio announces FDA granted ODD to MB-106. |
|
|
Jun 22, 2022 |
188 |
| General Construction Company uses Terex Cranes for Dubai Creek development. |
Mark Dowdall |
|
Jun 21, 2022 |
389 |
| General Construction Company uses Terex Cranes for Dubai Creek development. |
Mark Dowdall |
|
Jun 21, 2022 |
408 |
| Acepodia's ACE1831 Investigational New Drug application receives FDA approval to commence phase one first-in-human, multi-centre clinical study. |
|
|
Jun 21, 2022 |
235 |
| Acepodia's ACE1831 Investigational New Drug application receives FDA approval to commence phase one first-in-human, multi-centre clinical study. |
|
|
Jun 21, 2022 |
234 |
| EMA validates Bristol-Myers application for CAR T cell therapy Breyanzi. |
|
|
Jun 20, 2022 |
349 |
| T Cell Roles and Activity in Chronic Sclerosing Sialadenitis as IgG4-Related Disease: Current Concepts in Immunopathogenesis. |
Ibrahem, Hazim Mahmoud |
|
Jun 20, 2022 |
15196 |
| Integrated Bioinformatic Analysis of DNA Methylation and Immune Infiltration in Endometrial Cancer. |
Dai, Fangfang; Wu, Jinglin; Deng, Zhimin; Li, Hengxing; Tan, Wei; Yuan, Mengqin; Yang, Dongyong; Liu |
Report |
Jun 20, 2022 |
4692 |
| CD96 Downregulation Promotes the Immune Response of CD4 T Cells and Associates with Ankylosing Spondylitis. |
Wu, Fengqing; Yang, Huan; Xu, Xiao; Ren, Conglin; Zheng, Yang; Zhang, Helou; Cai, Bingbing |
Report |
Jun 19, 2022 |
6503 |
| The Potential Diagnostic Value of Immune-Related Genes in Interstitial Fibrosis and Tubular Atrophy after Kidney Transplantation. |
Yang, Bin; Shi, Dike; Chen, Yahong; Zhu, Yi |
|
Jun 17, 2022 |
7218 |
| Prediction of Immune Infiltration Diagnostic Gene Biomarkers in Kawasaki Disease. |
Ba, Hongjun; Wang, Yao; Zhang, Lili; Wang, Huishen; Huang, Zhan-Peng; Qin, Youzhen |
|
Jun 17, 2022 |
6069 |
| Kymera Therapeutics doses first patients in Phase 1 clinical trials assessing KT-333 and KT-413. |
|
|
Jun 17, 2022 |
176 |
| Kymera Therapeutics doses first patients in Phase 1 clinical trials assessing KT-333 and KT-413. |
|
|
Jun 17, 2022 |
177 |
| Sana presents data at ISSCR 2022 on transplanted allogeneic, hypoimmune cells. |
|
|
Jun 17, 2022 |
398 |
| Total skin electron beam therapy (TSEBT) in management of mycosis fungoides: A case series. |
|
|
Jun 16, 2022 |
1605 |
| Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant Tissue. |
Nguyen, Linh T.; Lo, Charlotte S.; Fyrsta, Michael; Nie, Jessica; Yam, Jennifer Y.; Yen, Pei-Hua; Le |
|
Jun 16, 2022 |
6301 |
| Kymera Therapeutics begins dosing in Phase 1 oncology trials of KT-333, KT-413. |
|
|
Jun 15, 2022 |
163 |
| Affini-T Therapeutics, Metagenomi Forge Gene Editing Partnership to Advance Cell Therapies for Solid Tumor Patients. |
|
|
Jun 15, 2022 |
244 |
| lncRNA FR215775 Regulates Th2 Differentiation in Murine Allergic Rhinitis. |
Ma, Yue; Shi, Le; Zhao, Keqing; Zheng, Chunquan |
|
Jun 14, 2022 |
5405 |
| LNCRNA XIST Inhibits miR-377-3p to Hinder Th17 Cell Differentiation through Upregulating ETS1. |
Yao, Chen; Li, Chao; Liu, Zhijia; Xiao, Li; Bai, Hongwei; Shi, Bingyi |
|
Jun 14, 2022 |
3232 |
| Identification of Biomarkers Associated with Diagnosis of Osteoarthritis Patients Based on Bioinformatics and Machine Learning. |
Liang, Yihao; Lin, Fangzheng; Huang, Yunfei |
|
Jun 13, 2022 |
4201 |
| Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer. |
Shi, Jie; Yang, Xu; Wang, Xinmei; Luo, Yufeng; Zhou, Weixun; Luo, Hanhuan; Bianba, Zhaxi |
Report |
Jun 13, 2022 |
7957 |
| Mustang Bio announces updated interim data on Phase 1/2 trial of MB-106. |
|
|
Jun 13, 2022 |
300 |
| Homology Medicines says FDA lifts clinical hold on pheNIX gene therapy trial. |
|
|
Jun 13, 2022 |
189 |
| Scientists discover the best way to protect yourself against Covid; So which is 'better' -the immunity produced from an infection or a vaccine? |
By, Grace C Roberts, University of Leeds & Lena Glaser, Queen's University Belfast |
|
Jun 13, 2022 |
1075 |
| Scientists discover the best way to protect yourself against Covid; So which is 'better' -the immunity produced from an infection or a vaccine? |
By, Grace C Roberts, University of Leeds & Lena Glaser, Queen's University Belfast |
|
Jun 13, 2022 |
1075 |
| Genmab announces Phase 2 results of epcoritamab in relapsed/refractory LBCL. |
|
Financial report |
Jun 12, 2022 |
375 |
| Crispr Therapeutics presents results from Phase 1 COBALT-LYM trial of CTX130. |
|
|
Jun 12, 2022 |
440 |
| lncRNA SNHG15 as a ceRNA modulates Osteoclast Differentiation, Proliferation, and Metastasis by Sponging miR-381-3p/NEK2 Axis. |
Wang, YiFan; Zhu, GuanYin; Pei, Fang; Zhao, ZhiHe |
|
Jun 12, 2022 |
5156 |
| Integrated Bioinformatics Identifies FREM1 as a Diagnostic Gene Signature for Heart Failure. |
Jiang, Chenyang; Jiang, Weidong |
|
Jun 11, 2022 |
4969 |
| Breakthrough in cancer care. |
|
|
Jun 11, 2022 |
187 |
| Thymus cancer: Four everyday health issues that could be a warning sign; Some common health complaints are easy to ignore or blame on other factors, but not speaking to your GP about these issues could mean missing an early cancer diagnosis. Cancers of the thymus gland can affect your airways, leading to wheezing and feeling dizzy. |
By, William Morgan |
|
Jun 11, 2022 |
567 |
| Sonoma Biotherapeutics Receives FDA Clearance of Investigational New Drug Application for SBT115301, an Effector T Cell-Modulating Biologic for Autoimmune Diseases. |
|
|
Jun 10, 2022 |
232 |
| Gritstone announces results from preclinical study of samRNA vaccine. |
|
|
Jun 10, 2022 |
187 |
| UK's CrowdToLive, Qatar's Al Adaam Real Estate joining forces. |
|
|
Jun 9, 2022 |
336 |
| Updated Data for Janssen's Bispecific Teclistamab Suggest Continued Deep and Durable Responses in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma. |
|
|
Jun 8, 2022 |
1024 |
| miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma. |
Lu, Xiaoyuan; Jing, Li; Liu, Sicong; Wang, Haihong; Chen, Buze |
|
Jun 8, 2022 |
8073 |
| Blood Stasis Syndrome Accelerates the Growth and Metastasis of Breast Cancer by Promoting Hypoxia and Immunosuppressive Microenvironment in Mice. |
Jin, Lu; Tang, Biqiang; Liu, Xia; Mao, Weiye; Xia, Linying; Du, Yueguang; Ji, Bing |
|
Jun 7, 2022 |
6157 |
| Kiromic BioPharma expands Gamma Delta T cell product pipeline. |
|
|
Jun 7, 2022 |
274 |
| Immatics, Editas Medicine announce strategic collaboration and licensing pact. |
|
|
Jun 7, 2022 |
223 |
| Adicet Bio outlines data from ADI-001 study at ASCO meeting. |
|
|
Jun 6, 2022 |
289 |
| In8bio announces safety, durability data from Phase 1 trial of INB-200. |
|
|
Jun 6, 2022 |
396 |
| Portage Biotech presents early data from Phase 1/2 study of PORT-2. |
|
|
Jun 6, 2022 |
210 |
| Kite announces longer-term follow-up results from Tecartus studies. |
|
|
Jun 5, 2022 |
503 |
| Hookipa Pharma announces Phase 1 data, Phase 2 plans for HB-200 program. |
|
|
Jun 5, 2022 |
644 |
| TC BioPharm Prices USD 4M Underwritten Public Offering. |
|
|
Jun 3, 2022 |
206 |
| TC BioPharm Prices USD 4M Underwritten Public Offering. |
|
|
Jun 3, 2022 |
204 |
| Immatics, Bristol-Myers expand alliance to pursue TCR-T and/or CAR-T programs. |
|
|
Jun 2, 2022 |
235 |
| Regeneron plans to buy Sanofi's stake in collaboration on Libtayo. |
|
|
Jun 2, 2022 |
453 |
| T-cell experiment shrinks tumors. |
LAURAN NEERGAARD AP Medical Writer |
|
Jun 2, 2022 |
246 |
| IL6 Induces mtDNA Leakage to Affect the Immune Escape of Endometrial Carcinoma via cGAS-STING. |
Zeng, Xue; Li, Xiaosong; Zhang, Yundong; Cao, Chaoxia; Zhou, Qin |
|
Jun 2, 2022 |
6242 |
| Calorie Restriction Can Positively Affect Immune Health. |
|
|
Jun 1, 2022 |
167 |
| Kymera Therapeutics to present preclinical data at EULAR 2022 Congress. |
|
|
Jun 1, 2022 |
180 |
| Eureka Therapeutics, City of Hope Treat First Patient with GPC3 Targeting ARTEMIS T Cells for Advanced Liver Cancer. |
|
|
Jun 1, 2022 |
364 |
| Flow Cytometric Detection of the Double-Positive ([CD4.sup.+][CD8.sup.+])/[PD-1.sup.bright] T-Cell Subset Is Useful in Diagnosing Nodular Lymphocyte-Predominant Hodgkin Lymphoma. |
Chen, Zhongchuan Will; Wizniak, Juanita; Shang, Chuquan; Lai, Raymond |
Report |
Jun 1, 2022 |
7418 |
| Janux Therapeutics Receives FDA Clearance of Investigational New Drug Application for JANX007, a PSMA-TRACTr for Metastatic Castration-Resistant Prostate Cancer. |
|
|
May 31, 2022 |
350 |
| Perianal ulcerative tuberculosis: A case report. |
Lao, Weifeng; Mao, Weifang |
Clinical report |
May 31, 2022 |
1649 |
| Serum Scavenging Capacity and Folliculogenesis Impact following Flaxseed Consumption in the First-Generation Mice Pups. |
Pourjafari, Fahimeh; Haghpanah, Tahereh; Grazia Palmerini, Maria; Ezzatabadipour, Massood |
|
May 30, 2022 |
4452 |
| Novartis' Kymriah CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma receives FDA approval. |
|
|
May 30, 2022 |
165 |
| Novartis' Kymriah CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma receives FDA approval. |
|
|
May 30, 2022 |
166 |
| Therapeutical Significance of Serpina3n Subsequent Cerebral Ischemia via Cytotoxic Granzyme B Inactivation. |
Aslam, Mehwish Saba; Aslam, Mobeena Saba; Aslam, Komal Saba; Iqbal, Asia; Yuan, Liudi |
Report |
May 29, 2022 |
6706 |
| Clinical Factors of Blood Transfusion-Related Acute Lung Injury and Changes in Levels of Treg-Related Cytokines. |
Sun, Lifang; Liu, Yu |
|
May 27, 2022 |
3478 |
| LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting. |
|
|
May 27, 2022 |
514 |
| Bolt Biotherapeutics to present ex vivo data on myeloid cell landscape. |
|
|
May 27, 2022 |
177 |
| Osivax Provides Clinical Development Update on Lead Influenza Vaccine Candidate OVX836. |
|
|
May 26, 2022 |
670 |
| Bristol-Myers' Breyanzi ASCO data to show 'substantial durable response' in LBCL. |
|
|
May 26, 2022 |
225 |
| PDS Biotechnology announces presentation of Phase 2 data on PDS0101 at ASCO. |
|
|
May 26, 2022 |
165 |
| Bone Mesenchymal Stem Cell-Derived Exosome-Enclosed miR-181a Induces CD4[sup.+]CD25[sup.+]FOXP3[sup.+] Regulatory T Cells via SIRT1/Acetylation-Mediated FOXP3 Stabilization. |
Wang, Renyong; Li, Ruixue; Li, Tiehan; Zhu, Lei; Qi, Zongze; Yang, Xiaokui; Wang, Huan |
|
May 26, 2022 |
4685 |
| Revisited Cyclophosphamide in the Treatment of Lupus Nephritis. |
Quan, Xiao-ying; Chen, Hao-tao; Liang, Si-qin; Yang, Chen; Yao, Cui-wei; Xu, Yong-zhi; Liu, Hua-feng |
Report |
May 26, 2022 |
8112 |
| Long-Term GAD-alum Treatment Effect on Different T-Cell Subpopulations in Healthy Children Positive for Multiple Beta Cell Autoantibodies. |
Salami, Falastin; Spiliopoulos, Lampros; Maziarz, Marlena; Lundgren, Markus; Brundin, Charlotte; Ben |
|
May 25, 2022 |
6112 |
| Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia. |
Lee, Le Jie; Hassan, Norfarazieda; Idris, Siti Zuleha; Subbiah, Suresh Kumar; Seow, Heng Fong; Mohta |
|
May 23, 2022 |
9128 |
| Novel Immunotherapy Developed by City of Hope Could Provide New Treatment Model for SARS-CoV-2 Patients. |
|
|
May 23, 2022 |
592 |
| LATEST COMPANY NEWS. |
|
|
May 23, 2022 |
22635 |
| Machine Learning-Based Integration Develops a Pyroptosis-Related lncRNA Model to Enhance the Predicted Value of Low-Grade Glioma Patients. |
Wu, Jie; Lu, Lichun; Wang, Chen; Jiang, Feng |
|
May 19, 2022 |
6038 |
| Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature. |
Ji, Dan; Zhong, Rongfang; Fan, Song |
Report |
May 19, 2022 |
9190 |
| TScan Therapeutics presents preclinical data from solid tumor program. |
|
|
May 19, 2022 |
840 |
| Allogene Therapeutics presents preclinical data on allogeneic CAR T cells. |
|
|
May 19, 2022 |
286 |
| Atara provides update on Bayer collaboration. |
|
|
May 19, 2022 |
295 |
| TC Biopharm forms scientific advisroy board for cell therapy development. |
|
|
May 18, 2022 |
158 |
| Osivax Enters Research Collaboration with the NIAID for the Evaluation of Combination Approach to Broad-Spectrum Influenza Vaccines. |
|
|
May 18, 2022 |
509 |
| A Mechanistic Insight into the Pathogenic Role of Interleukin 17A in Systemic Autoimmune Diseases. |
Bisoendial, Radjesh; Lubberts, Erik |
|
May 17, 2022 |
12695 |
| In8bio announces data emerging from iPSC-based gamma-delta T cell platform. |
|
|
May 17, 2022 |
230 |
| Poseida Therapeutics to present data from anti-c-kit CAR-T cells studies. |
|
|
May 17, 2022 |
216 |
| FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma. |
Wu, Shaobo; Liang, Yuxia; Zang, Qijuan; Xing, Zixuan; Yin, Pan; Sun, Ruifang; Dai, Bingling |
|
May 14, 2022 |
5575 |
| Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer. |
Wei, Cheng; Li, Minzhe; Lin, Shaofeng; Xiao, Jun |
Report |
May 13, 2022 |
7611 |
| Kiromic BioPharma reports Q1 EPS (48c) vs. (53c) last year. |
|
Financial report |
May 13, 2022 |
154 |
| Mustang Bio says MB-106 trial selected for oral presentation at EHA2022. |
|
|
May 12, 2022 |
244 |
| Mustang Bio reports Q1 EPS (20c) vs. (19c) last year. |
|
Financial report |
May 12, 2022 |
209 |
| Fourth Covid vaccine provides 'a substantial boost to immunity', according to new study; Several countries have now deployed fourth doses of the Covid-19 vaccine, but the clinical need, effectiveness, timing, and dose of a fourth dose remain uncertain. |
By, Jess Knibbs |
|
May 12, 2022 |
653 |
| Abrine Elicits Liver Carcinoma Immunity and Enhances Antitumor Efficacy of Immune Checkpoint Blockade by Modulating PD-L1 Signaling. |
Zhang, Shaowu |
|
May 12, 2022 |
5425 |
| hsa-miR-9-5p-Mediated TSPAN9 Downregulation Is Positively Related to Both Poor Hepatocellular Carcinoma Prognosis and the Tumor Immune Infiltration. |
Tan, Shengkui; Song, Xin; Zhang, Chenchen; Sun, Yishu; Zhang, Jiaxi; Zhang, Zhongqi; Zhang, Rongchen |
|
May 12, 2022 |
5234 |
| The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors. |
Chang, Guodong; Chen, Yingwei; Liu, Zichang; Wang, Yong; Ge, Wenkun; Kang, Yongan; Guo, Shuling |
|
May 12, 2022 |
4682 |
| Comprehensive Analysis of PDLIM3 Expression Profile, Prognostic Value, and Correlations with Immune Infiltrates in Gastric Cancer. |
Hu, Xinpeng; Chen, Minfeng; Ruan, Qiang; Shi, Changzheng; Pan, Jinghua; Luo, Liangping |
|
May 12, 2022 |
8206 |
| Rationale for the Use of Cord Blood in Hypoxic-Ischaemic Encephalopathy. |
Zdolinska-Malinowska, Izabela; Boruczkowski, Dariusz; Holowaty, Dominika; Krajewski, Pawel; Snarski, |
|
May 11, 2022 |
10300 |
| Corvus Pharmaceuticals provides updates at R&D symposium. |
|
|
May 10, 2022 |
225 |
| Adicet Presents Preclinical Data Highlighting Potential Advantages of the Non-Gene-Edited Approach for its Investigational Allogeneic Gamma Delta CAR T Cell Therapy Targeting CD20 for B Cell Malignancies. |
|
|
May 10, 2022 |
294 |
| Epigenetic Regulation of IFI44L Expression in Monocytes Affects the Functions of Monocyte-Derived Dendritic Cells in Systemic Lupus Erythematosus. |
Luo, Shuaihantian; Wu, Ruifang; Li, Qianwen; Zhang, Guiying |
|
May 10, 2022 |
5694 |
| Crosstalk between ILC2s and Th2 CD4[sup.+] T Cells in Lung Disease. |
Mi, Lan-lan; Guo, Wei-wei |
|
May 10, 2022 |
11623 |
| Achilles Therapeutics doses first patient with higher dose cNeT in trial. |
|
|
May 9, 2022 |
199 |
| Equillium announces three poster presentations at IMMUNOLOGY2022. |
|
|
May 9, 2022 |
586 |
| Enlivex Therapeutics announces poster presentation of data on Allocetra. |
|
|
May 9, 2022 |
308 |
| A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective. |
Bao, Haili; Luo, Yi; Ding, Guoshan; Fu, Zhiren |
|
May 7, 2022 |
7677 |
| AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer. |
Li, Xubin; Zhang, Mengqiao; Yu, Xue; Xue, Mei; Li, Xiaowei; Ma, Chao; Jia, Wei |
|
May 7, 2022 |
4716 |
| Development of a Clinically Oriented Model to Predict Antitumor Effects after PD-1/PD-L1 Inhibitor Therapy. |
Wang, Xueping; He, Zhonglian; Liu, Wen; Han, Runkun; Li, Huilan; Dai, Shuqin; Zhang, Lin |
|
May 4, 2022 |
4996 |
| My little miracle, by new mum saved by Christie; CANCER PATIENT SAVED FROM INFERTILITY THANKS TO NEW TREATMENT. |
PAUL BRITTON |
|
May 3, 2022 |
598 |
| BABY I FEARED I'D NEVER HAVE; Cancer therapy mum's miracle. |
AMY-CLARE MARTIN |
|
May 3, 2022 |
192 |
| Cancer survivor who feared she was infertile gives birth after innovative cell therapy; Sammy Gray is one of the first women to give birth after receiving innovative new treatment for non-Hodgkin's Lymphoma after she received the heartbreaking cancer diagnosis in 2018. |
By, Amy-Clare Martin |
|
May 3, 2022 |
209 |
| Inmagene Biopharmaceuticals receives USFDA approval over Phase one clinical development of IMG-007. |
|
|
May 2, 2022 |
171 |
| Intellia presents preclinical data on CRISPR-engineered allogeneic platform. |
|
|
May 2, 2022 |
215 |
| CERo Therapeutics' Multifunctional CER T Cells Synergize with Standard-of-Care Small Molecule Anti-Tumor Inhibitors Across Hematologic and Solid Tumor Models. |
|
|
May 2, 2022 |
440 |
| Inflammatory cells in the ascending aortic aneurysm in patients with type 2 diabetes versus patients with hypertension. |
Milutinovic, Aleksandra; Zorc-Pleskovic, Ruda |
Report |
May 1, 2022 |
4903 |
| Altered molecular pathways and prognostic markers in active systemic juvenile idiopathic arthritis: Integrated bioinformatic analysis. |
Ren, Yi; Labinsky, Hannah; Palmowski, Andriko; Backer, Henrik; Muller, Michael; Kienzle, Arne |
Report |
Apr 30, 2022 |
7377 |
| Role of CD4[sup.+]T, CD8[sup.+]T Cells, and CD4[sup.+]T/CD8[sup.+]T Cell Ratio in Gastric Cancer and Its Clinical Significance. |
Han, Jingqi; Zhao, Linglin; Wu, Jianying; Diao, Yinzhuo; Guo, Qijing; Yang, Jie; Luo, Yushuang |
|
Apr 30, 2022 |
6154 |
| IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer. |
Li, Guangyao; Wang, Yandong; Cheng, Ya |
|
Apr 29, 2022 |
7025 |
| Factors Affecting the Readmission of Patients with Pancreatic Cancer after Surgery. |
Gu, Xiaojing; Zhou, Wei; Han, Juan |
|
Apr 29, 2022 |
3985 |
| Bone Marrow-Derived Cells Contribute to the Maintenance of Thymic Stroma including TECs. |
Chakrabarti, Shami; Hoque, Mohammed; Jamil, Nawshin Zara; Singh, Varan J.; Pollacksmith, Daniel; Mee |
|
Apr 29, 2022 |
12975 |
| Scientists explore link between vitamin D, inflammation in Covid patients. |
|
|
Apr 29, 2022 |
413 |
| ISMAIL MOSTAFA AND YOUSSEF MAHMOUD RECEIVE CTL AWARD FOR OUTSTANDING PERFORMANCE. |
|
|
Apr 28, 2022 |
208 |
| Cellectis publishes two articles on UCART123. |
|
|
Apr 28, 2022 |
266 |
| lncRNA STAT4-AS1 Inhibited TH17 Cell Differentiation by Targeting ROR? t Protein. |
He, Hanlin; Qiu, Xiangjie; Qi, Mingming; Bajinka, Ousman; Qin, Ling; Tan, Yurong |
|
Apr 28, 2022 |
7581 |
| Different In Situ Immune Patterns between Primary Tumor and Lymph Node in Non-Small-Cell Lung Cancer: Potential Impact on Neoadjuvant Immunotherapy. |
Ye, Zheng-Hao; Long, Hao; Zhao, Ze-Rui |
|
Apr 28, 2022 |
7617 |
| The Diagnostic and Predictive Significance of Immune-Related Genes and Immune Characteristics in the Occurrence and Progression of IgA Nephropathy. |
Qing, Jian-Bo; Song, Wen-Zhu; Li, Chang-Qun; Li, Ya-Feng |
|
Apr 28, 2022 |
7102 |
| Spatiotemporal Dynamics of a Delayed Viral Infection Model with Two Modes of Transmission and Immune Impairment. |
Miao, Hui; Jiao, Meiyan |
|
Apr 26, 2022 |
5793 |
| The Temporal and Spatial Changes of Th17, Tregs, and Related Cytokines in Epilepsy Lesions. |
Wei, Jingbo; Liu, Hui; Liu, Ziqi; Jiang, Xiaohua; Wang, Weiping |
|
Apr 26, 2022 |
5389 |
| CTL RECOGNIZES SIS AND PEER TUTORS. |
|
|
Apr 26, 2022 |
280 |
| LANCL1 as the Key Immune Marker in Neuropathic Pain. |
Shi, Yu; Zhang, XueFei; Fang, Qian; Zhan, Hongrui; Wang, Xianglong; Huang, Xiyan; Fan, Tao |
|
Apr 25, 2022 |
5083 |
| Suzhou Porton Advanced Solutions and Guizhou Sinorda Biomedicine enter into long-term strategic partnership. |
|
|
Apr 25, 2022 |
153 |
| Suzhou Porton Advanced Solutions and Guizhou Sinorda Biomedicine enter into long-term strategic partnership. |
|
|
Apr 25, 2022 |
154 |
| Nkarta announces preliminary dose finding data for two NK cell programs. |
|
|
Apr 25, 2022 |
255 |
| Mustang Bio announces updated interim Phase 1/2 data for MB-106. |
|
|
Apr 25, 2022 |
258 |
| Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives. |
Liang, Jiaqi; Bi, Guoshu; Shan, Guangyao; Jin, Xing; Bian, Yunyi; Wang, Qun |
|
Apr 22, 2022 |
10130 |
| AIM ImmunoTech provides summary of data from checkpoint blockade therapies. |
|
|
Apr 21, 2022 |
319 |
| Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T. |
|
|
Apr 21, 2022 |
370 |
| Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer via FOSB-Mediated Downregulation of MicroRNA-22 through BATF3/PD-L1 Pathway. |
Tian, Jiale; Wang, Weiwei; Zhu, Jichao; Zhuang, Yun; Qi, Chunrun; Cai, Zhengxin; Yan, Wenhui |
|
Apr 20, 2022 |
7814 |
| Revealing Potential Diagnostic Gene Biomarkers Associated with Immune Infiltration in Patients with Renal Fibrosis Based on Machine Learning Analysis. |
Sun, Yu-Chao; Qiu, Zhen-Zhen; Wen, Fu-Li; Yin, Jin-Quan; Zhou, Hao |
Report |
Apr 20, 2022 |
5083 |
| Kite Receives US FDA Approval of New CAR T-Cell Therapy Manufacturing Facility in Maryland. |
|
|
Apr 20, 2022 |
523 |
| Humanigen's lenzilumab reduces cytokine release syndrome in published study. |
|
|
Apr 20, 2022 |
198 |
| Kite gets FDA approval of CAR T-cell therapy manufacturing facility in Maryland. |
|
|
Apr 19, 2022 |
424 |
| Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19. |
Alsalman, Alhasan; Al-Mterin, Mohammad A.; Elkord, Eyad |
|
Apr 19, 2022 |
11606 |
| Covid-19 will not cause AIDS like HIV does, says top virologist. |
|
|
Apr 18, 2022 |
207 |
| Considering Computational Mathematics IGHG3 as Malignant Melanoma Is Associated with Immune Infiltration of Malignant Melanoma. |
Si, Mengqing; Cao, Xianwei |
Report |
Apr 18, 2022 |
7508 |
| Subcellular Proteome Analysis Reveals Apoptotic Vulnerability of T-Cell Acute Lymphoblastic Leukemia. |
Song, Xiaolei; Wu, Xiaojing; Zhang, Zihan; Cui, Zhangxiu; Zheng, Yong; Sun, Jian |
Report |
Apr 15, 2022 |
5090 |
| Comprehensive Bioinformatics Analysis of Gasdermin Family of Glioma. |
Zi, Huaduan; Tuo, Zhan; He, Qianyuan; Meng, Jingshu; Hu, Yan; Li, Yan; Yang, Kunyu |
|
Apr 15, 2022 |
7437 |
| Role of Apoptosis in HIV Pathogenesis. |
Jabea Ekabe, Cyril; Asaba Clinton, Njinju; Agyei, Eugene Kusi; Kehbila, Jules |
|
Apr 14, 2022 |
7906 |
| Proteomic Profiling and Functional Analysis of B Cell-Derived Exosomes upon Pneumocystis Infection. |
Ma, Dan; Zhang, Qian-Yu; Rong, Heng-Mo; Zhai, Kan; Tong, Zhao-Hui |
|
Apr 14, 2022 |
9231 |
| Novel Covid vax may provide protection for cancer patients. |
|
|
Apr 14, 2022 |
386 |
| Novel Covid vax may provide protection for cancer patients. |
|
|
Apr 14, 2022 |
386 |
| Osivax welcomes new board member & announces upcoming presentation at World Vaccine Congress. |
|
|
Apr 14, 2022 |
154 |
| Osivax welcomes new board member & announces upcoming presentation at World Vaccine Congress. |
|
|
Apr 14, 2022 |
155 |
| Oncolytics' pelareorep shows anti-cancer potential in publication. |
|
|
Apr 14, 2022 |
158 |
| Allogene Therapeutics announces unveiling of Cell Forge 1. |
|
|
Apr 14, 2022 |
179 |
| SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo. |
|
|
Apr 14, 2022 |
698 |
| Allogene Therapeutics publishes preclinical data on ALLO-316. |
|
|
Apr 13, 2022 |
240 |
| Mustang Bio plans to initiate Phase 1 trial combining MB-101 with MB-108. |
|
|
Apr 13, 2022 |
450 |
| Portage Biotech highlights data presented on PORT-5 at AACR 2022. |
|
|
Apr 13, 2022 |
207 |
| Hookipa Pharma announces preclinical data on arenaviral immunotherapies. |
|
|
Apr 13, 2022 |
499 |
| Cross Talk between Inflammation and Metabolic Disorders. |
Chen, Jie; Yang, Yan; Kong, Wen |
|
Apr 13, 2022 |
1317 |
| Sarcoidosis: An experience from a tertiary care center in Karachi Pakistan. |
Khan, Mustafa Ali; Ibad, Hamza Ahmed; Hussain, Sahibzada Muhammad Hamid; Hassan, Maryam; Ali, Akbar |
Report |
Apr 13, 2022 |
2279 |
| Prediction of Prognosis and Recurrence of Bladder Cancer by ECM-Related Genes. |
Zhao, Hongfan; Chen, Zihao; Fang, Yunze; Su, Mingqiang; Xu, Yipeng; Wang, Zhifeng; Gyamfi, Michael A |
|
Apr 12, 2022 |
8722 |
| Training T-cells how to destroy breast cancer; Cardiff University professor Awen Gallimore explains her pioneering work investigating how we can help our immune systems recognise and destroy breast cancer... |
|
|
Apr 12, 2022 |
697 |
| Simple delivery method that enhances a promising cancer treatment. |
|
|
Apr 12, 2022 |
456 |
| Achilles Therapeutics announces manufacturing expansion in UK, US. |
|
|
Apr 12, 2022 |
173 |
| Harpoon Therapeutics presents preclinical data for TriTAC-XR platform. |
|
|
Apr 12, 2022 |
176 |
| Molecular Templates reviews six poster presentations at AACR 2022 meeting. |
|
|
Apr 12, 2022 |
422 |
| Scientists Find New Technique to Treat Cancer Tumor. |
Asharq Al-Awsat |
|
Apr 12, 2022 |
343 |
| AIM reports data from Phase 1 study of Ampligen for treatment of breast cancer. |
|
|
Apr 11, 2022 |
202 |
| Training T-cells how to destroy breast cancer; Cardiff University professor Awen Gallimore and her team are investigating how we can help our immune systems recognise and destroy breast cancer. Here, she explains more about her pioneering work which she hopes will help lead to more effective treatments for the disease. |
AgendaWM Edited by Mark Smith 029 2024 3937 mark.smith@walesonline.co.uk |
|
Apr 11, 2022 |
704 |
| BioNTech presents data from BNT211 trial at AACR meeting. |
|
|
Apr 11, 2022 |
384 |
| Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies. |
|
|
Apr 8, 2022 |
320 |
| IsoPlexis to present data generated using it Duomic platform. |
|
|
Apr 8, 2022 |
243 |
| MEI Pharma announces presentations at AACR Annual Meeting. |
|
|
Apr 8, 2022 |
339 |
| Compass Therapeutics presents data on CTX-8371 at AACR meeting. |
|
|
Apr 8, 2022 |
227 |
| iTeos Therapeutics presents new data for EOS-448/GSK4428859A. |
|
|
Apr 8, 2022 |
318 |
| Genocea presents initial data from GEN-011 Phase 1/2a trial. |
|
|
Apr 8, 2022 |
189 |
| Caribou Biosciences data supports an expected IND application for CB-011 in 2022. |
|
|
Apr 8, 2022 |
277 |
| Adaptimmune presents MAGE-A4 expression data from screening protocol. |
|
|
Apr 8, 2022 |
226 |
| Corbus presents first preclinical data for CRB-601 at AACR. |
|
|
Apr 8, 2022 |
200 |
| Arcellx presents pre-clinical data for ACLX-002 at AACR. |
|
|
Apr 8, 2022 |
181 |
| Twist in antibody discovery pact for T-cell therapeutics with MediSix. |
|
|
Apr 7, 2022 |
172 |
| New Paradigm in Cell Therapy Using Sperm Head to Restore Brain Function and Structure in Animal Model of Alzheimer's Disease: Support for Boosting Constructive Inflammation vs. Anti-Inflammatory Approach. |
Pakravan, Nafiseh; Abbasi, Ardeshir; Hassan, Zuhair Mohammad |
|
Apr 7, 2022 |
10651 |
| Determination of B and T Cell Epitopes in Neospora caninum Immune Mapped Protein-1 (IMP-1): Implications in Vaccine Design against Neosporosis. |
Nazari, Naser; Kordi, Bahareh; Maleki, Bahman; Shams, Morteza; Azizi, Esfandiar; Majidiani, Hamidrez |
Report |
Apr 7, 2022 |
6824 |
| Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature. |
Lu, Lin; Zhang, Peiling; Cao, Xiaofei; Guan, Mingmei |
|
Apr 6, 2022 |
7371 |
| Hyper-Methylated Hub Genes of T-Cell Receptor Signaling Predict a Poor Clinical Outcome in Lung Adenocarcinoma. |
Hu, Zixin; Xue, Chongxiang; Zheng, Jiabin; Lu, Xingyu; Li, Jia; Dong, Huijing; Yu, Yixuan |
|
Apr 6, 2022 |
10099 |
| Effects of Sodium Chlorophyllin Copper on APO-1 Expression in Bone Marrow Mesenchymal Stem Cells of Rats with Aplastic Anaemia. |
Jin, Xin; Dai, Guanhai; Xuan, Liyang; Zhang, Meng; Jiang, Huifang; Sui, Yang |
|
Apr 6, 2022 |
5216 |
| miR-155: An Important Role in Inflammation Response. |
Hu, Jingyan; Huang, Songli; Liu, Xiaoli; Zhang, Yuan; Wei, Shengli; Hu, Xiuhua |
|
Apr 6, 2022 |
10515 |
| Neospora caninum SRS2 Protein: Essential Vaccination Targets and Biochemical Features for Next-Generation Vaccine Design. |
Asghari, Ali; Kordi, Bahareh; Maleki, Bahman; Majidiani, Hamidreza; Shams, Morteza; Naserifar, Razi |
Report |
Apr 6, 2022 |
8347 |
| Fujifilm Buys Atara Biotherapeutics Cell Therapy Manufacturing Facility. |
|
|
Apr 6, 2022 |
302 |
| Fujifilm Buys Atara Biotherapeutics Cell Therapy Manufacturing Facility. |
|
|
Apr 6, 2022 |
325 |
| Citius Pharmaceuticals reports data from I/ONTAK trial. |
|
|
Apr 6, 2022 |
350 |
| Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi for Certain Forms of Relapsed or Refractory Large B-cell Lymphoma. |
|
|
Apr 6, 2022 |
496 |
| Precigen's PRGN-3006 UltraCAR-T receives US FDA Fast Track designation. |
|
|
Apr 5, 2022 |
212 |
| Precigen's PRGN-3006 UltraCAR-T receives US FDA Fast Track designation. |
|
|
Apr 5, 2022 |
213 |
| Tonix extends sponsored research agreement with Kansas State University. |
|
|
Apr 5, 2022 |
257 |
| Now Muzik set to release Sound Sultan's 9th album. |
|
|
Apr 5, 2022 |
431 |
| Immunocore announces EC approval of KIMMTRAK. |
|
|
Apr 4, 2022 |
236 |
| Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer. |
Liu, Chao; Li, Xiaohui; Li, Aijie; Zou, Wenxue; Huang, Rui; Hu, Xiaoyu; Yu, Jinming |
|
Apr 4, 2022 |
4028 |
| Evolution of Immunity and Immune System in Humans. |
Anam, Mujibul |
|
Apr 1, 2022 |
773 |
| Immunoglobin G4-Related Diseases. |
Tinazli, Mehtap; Tinazli, Remzi |
|
Apr 1, 2022 |
4414 |
| Overexpression of miR-490-5p/miR-490-3p Potentially Induces IL-17-Producing T Cells in Patients With Breast Cancer. |
Seif, Farhad; Vaseghi, Hajar; Ariana, Mehdi; Ganji, Shahla Mohammad; Nazari, Mohammad; Rad, Kowsar K |
Report |
Apr 1, 2022 |
4620 |
| New Vaccine Component May Provide Greater Immune Response. |
|
|
Apr 1, 2022 |
185 |
| Lymphoproliferative Disorders as Potential Candidates for CD30-Targeted Therapies. |
Schwarting, Roland; Behling, Eric; Allen, Ashleigh; Arguello-Guerra, Vivian; Budak-Alpdogan, Tulin |
Report |
Apr 1, 2022 |
14849 |
| Assessment of Clonotypic Rearrangements and Minimal Residual Disease in Lymphoid Malignancies: A Large Cancer Center Experience Using clonoSEQ. |
Hussaini, Mohammad O.; Srivastava, Jaya; Lee, Lik Wee; Nishihori, Taiga; Shah, Bijal D.; Alsina, Mel |
Report |
Apr 1, 2022 |
7653 |
| Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination. |
Dulovic, Alex; Strengert, Monika; Ramos, Gema Morillas; Becker, Matthias; Griesbaum, Johanna; Junker |
Report |
Apr 1, 2022 |
4963 |
| Unique Clinical, Immune, and Genetic Signature in Patients with Borrelial Meningoradiculoneuritis. |
Ogrinc, Katarina; Hernandez, Sergio A.; Korva, Misa; Bogovic, Petra; Rojko, Tereza; Lusa, Lara; Chiu |
Report |
Apr 1, 2022 |
6710 |
| Govt plans coal conversion to gas, liquid fuels. |
|
|
Mar 31, 2022 |
781 |
| Surface achieves $30M milestone with first patient dosed in Phase 1 study. |
|
|
Mar 31, 2022 |
153 |
| Jasper Therapeutics to present updated data on JSP191. |
|
|
Mar 31, 2022 |
171 |
| Portage Biotech provides update on clinical-stage, development programs. |
|
|
Mar 31, 2022 |
430 |
| Understanding of Immune Escape Mechanisms and Advances in Cancer Immunotherapy. |
Aktar, Nasrin; Yueting, Chen; Abbas, Muhammad; Zafar, Hajra; Paiva-Santos, Ana Cláudia; Zhang, Qin; |
|
Mar 31, 2022 |
11813 |
| Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma. |
Sun, Ji; Cheng, Nan-sheng |
|
Mar 30, 2022 |
4719 |
| A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma. |
Lai, Xing; Wu, Ya-kun; Hong, Guo-qing; Li, Jun-ke; Luo, Qing; Yuan, Jin; Dai, Guo-hua |
|
Mar 30, 2022 |
4744 |
| Aspirin Suppressed PD-L1 Expression through Suppressing KAT5 and Subsequently Inhibited PD-1 and PD-L1 Signaling to Attenuate OC Development. |
Xiao, Xiyun; Zeng, Saitian; Li, Yanying; Li, Lingling; Zhang, Jiyan |
|
Mar 29, 2022 |
4124 |
| Sangamo Therapeutics Doses First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation. |
|
Clinical report |
Mar 29, 2022 |
1015 |
| In8bio presents clinical update on ongoing Phase 1 trial of INB-100. |
|
|
Mar 28, 2022 |
222 |
| Role and Function of Regulatory T Cell in Chronic Rhinosinusitis with Nasal Polyposis. |
Lei, Chenyang; Jiang, Juan; Zhang, Yanyan; Xiong, Gaoyun |
|
Mar 26, 2022 |
12204 |
| The Role of PDGFRA in Predicting Oncological and Immune Characteristics in Pancreatic Ductal Adenocarcinoma. |
Wu, Zijian; Xu, Jin; Tang, Rong; Wang, Wei; Zhang, Bo; Yu, Xianjun; Liu, Jiang |
|
Mar 26, 2022 |
7705 |
| Low Activation of CD8[sup.+] T Cells in response to Viral Peptides in Mexican Patients with Severe Dengue. |
Estrada-Jiménez, Tania; Flores-Mendoza, Lilian; Ávila-Jiménez, Laura; Vázquez-Rodríguez, Carlos Fran |
|
Mar 25, 2022 |
9056 |
| The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model. |
Mierzejewska, Jagoda; Wegierek-Ciura, Katarzyna; Rossowska, Joanna; Szczygiel, Agnieszka; Anger-Góra |
|
Mar 25, 2022 |
14056 |
| Govt explains why Oulanyah didn't get treatment in Seattle. |
|
|
Mar 25, 2022 |
339 |
| Govt explains why Oulanyah didn't get treatment in Seattle. |
|
|
Mar 25, 2022 |
360 |
| A Bioinformatics Study of Immune Infiltration-Associated Genes in Sciatica. |
Ma, Tao; Li, Guanhua; Ma, Yuheng; Ren, Zhaoqi; Xie, Houyun; Sun, Chaoyong; Tian, Lei |
|
Mar 24, 2022 |
2566 |
| Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma. |
Xiang, Jing; Chen, Xiaotong; Chen, Mengping; Hou, Jian |
Report |
Mar 23, 2022 |
8910 |
| Allogene announces preclinical publication results on allogeneic CAR T cells. |
|
Financial report |
Mar 23, 2022 |
280 |
| LATEST COMPANY NEWS. |
|
|
Mar 23, 2022 |
20431 |
| Coal conversion to gas, liquid fuels planned. |
|
|
Mar 22, 2022 |
793 |
| Bimbo Akintola Remembers Late Sound Sultan. |
|
|
Mar 19, 2022 |
305 |
| TEE GRANT WINNERS ANNOUNCED FOR 2022. |
|
|
Mar 17, 2022 |
445 |
| Neximmune, Zephyr AI announce strategic partnership in oncology. |
|
|
Mar 17, 2022 |
264 |
| OSE Immunotherapeutics reports positive long-term memory responses with COVID-19 vaccine candidate CoVepiT. |
|
|
Mar 17, 2022 |
180 |
| OSE Immunotherapeutics reports positive long-term memory responses with COVID-19 vaccine candidate CoVepiT. |
|
|
Mar 17, 2022 |
179 |
| Inflammatory Response-Related Long Non-Coding RNA Signature Predicts the Prognosis of Hepatocellular Carcinoma. |
Li, Xinyu; Zhang, Shuqiao; Zhang, Shijun; Kuang, Weihong; Tang, Chunzhi |
|
Mar 17, 2022 |
5691 |
| DT2216 Receives Orphan Drug Designation from the FDA for the Treatment of T-Cell Lymphoma. |
|
|
Mar 16, 2022 |
444 |
| Adaptimmune provides update of progress of '2-2-5-2' strategic plan. |
|
|
Mar 14, 2022 |
211 |
| Bach2: A Key Regulator in Th2-Related Immune Cells and Th2 Immune Response. |
Liu, Guo; Liu, Feng |
|
Mar 12, 2022 |
7998 |
| Mesenchymal Stem Cell-Secreted TGF-ß 1 Restores Treg/Th17 Skewing Induced by Lipopolysaccharide and Hypoxia Challenge via miR-155 Suppression. |
Xue, Ming; Zhang, Xiwen; Chen, Jianxiao; Liu, Feng; Xu, Jingyuan; Xie, Jianfeng; Yang, Yi |
|
Mar 12, 2022 |
8925 |
